These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38456874)

  • 1. Emulated Trial for Discharge Prescription of Guideline-Directed Medical Therapy and 15-Year Survival After Coronary Artery Bypass Graft Surgery.
    Moshkovitz Y; Orenstein L; Olmer L; Laufer K; Ziv A; Dankner R
    Mayo Clin Proc; 2024 May; 99(5):766-779. PubMed ID: 38456874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do practice gaps exist in evidence-based medication prescription at hospital discharge in patients undergoing coronary artery bypass surgery & coronary angioplasty?
    Pereira P; Kapoor A; Sinha A; Agarwal SK; Pande S; Khanna R; Srivastava N; Kumar S; Garg N; Tewari S; Goel P
    Indian J Med Res; 2017 Dec; 146(6):722-729. PubMed ID: 29664030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Underutilization of Medical Therapy in Patients Undergoing Endovascular Revascularization for Peripheral Artery Disease.
    Altin SE; Castro-Dominguez YS; Kennedy KF; Orion KC; Lanksy AJ; Abbott JD; Aronow HD
    JACC Cardiovasc Interv; 2020 Dec; 13(24):2911-2918. PubMed ID: 33357529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of preventive cardiovascular pharmacotherapy after coronary artery bypass graft surgery.
    Barry AR; Koshman SL; Norris CM; Ross DB; Pearson GJ
    Pharmacotherapy; 2014 May; 34(5):464-72. PubMed ID: 24877186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study.
    Rao C; Du J; Li X; Li J; Zhang H; Zhao Y; Hu S; Jiang L; Zheng Z;
    Am Heart J; 2016 Aug; 178():9-18. PubMed ID: 27502847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Socioeconomic Factors, Secondary Prevention Medication, and Long-Term Survival After Coronary Artery Bypass Grafting: A Population-Based Cohort Study From the SWEDEHEART Registry.
    Nielsen SJ; Karlsson M; Björklund E; Martinsson A; Hansson EC; Malm CJ; Pivodic A; Jeppsson A
    J Am Heart Assoc; 2020 Mar; 9(5):e015491. PubMed ID: 32114890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription Rates of Guideline-Directed Medications Are Associated With In-Hospital Mortality Among Japanese Patients With Acute Myocardial Infarction: A Report From JROAD - DPC Study.
    Nakao K; Yasuda S; Nishimura K; Noguchi T; Nakai M; Miyamoto Y; Sumita Y; Shishido T; Anzai T; Ito H; Tsutsui H; Saito Y; Komuro I; Ogawa H
    J Am Heart Assoc; 2019 Apr; 8(7):e009692. PubMed ID: 30909774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attainment of Guideline-Directed Medical Treatment in Stable Ischemic Heart Disease Patients With and Without Chronic Kidney Disease.
    Koutroumpakis E; Gosmanova EO; Stahura H; Jou S; Alreshq R; Ata A; Sidhu MS; Philbin E; Boden WE; Lyubarova R
    Cardiovasc Drugs Ther; 2019 Aug; 33(4):443-451. PubMed ID: 31123935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
    Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Guideline-Directed Medical Therapy on 10-Year Mortality after Revascularization for Patients with Chronic Limb-Threatening Ischemia.
    Hata Y; Iida O; Okamoto S; Ishihara T; Nanto K; Tsujimura T; Higashino N; Toyoshima T; Kitano I; Tsuji Y; Takahara M; Mano T
    J Atheroscler Thromb; 2023 Jun; 30(6):663-674. PubMed ID: 36031358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
    Goyal A; Alexander JH; Hafley GE; Graham SH; Mehta RH; Mack MJ; Wolf RK; Cohn LH; Kouchoukos NT; Harrington RA; Gennevois D; Gibson CM; Califf RM; Ferguson TB; Peterson ED;
    Ann Thorac Surg; 2007 Mar; 83(3):993-1001. PubMed ID: 17307447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity of Guideline-Directed Medical Therapy for Coronary Heart Disease and Ischemic Heart Failure Outcomes.
    Crosier R; Austin PC; Ko DT; Lawler PR; Stukel TA; Farkouh ME; Wang X; Spertus JA; Ross HJ; Lee DS
    Am J Med; 2021 May; 134(5):672-681.e4. PubMed ID: 33181105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between in-hospital guideline adherence and postdischarge major adverse outcomes of patients with acute coronary syndrome in Vietnam: a prospective cohort study.
    Nguyen T; Le KK; Cao HTK; Tran DTT; Ho LM; Thai TND; Pham HTK; Pham PT; Nguyen TH; Hak E; Pham TT; Taxis K
    BMJ Open; 2017 Oct; 7(10):e017008. PubMed ID: 28982823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of perioperative cardiac medical therapy among patients undergoing coronary artery bypass graft surgery.
    Filion KB; Pilote L; Rahme E; Eisenberg MJ
    J Card Surg; 2008; 23(3):209-15. PubMed ID: 18435634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease.
    Chen DC; Singh GD; Armstrong EJ; Waldo SW; Laird JR; Amsterdam EA
    Am J Cardiol; 2017 Apr; 119(8):1146-1152. PubMed ID: 28259239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of cardiovascular medical therapy among patients undergoing coronary artery bypass graft surgery: results from the ROSETTA-CABG registry.
    Okrainec K; Pilote L; Platt R; Eisenberg MJ
    Can J Cardiol; 2006 Aug; 22(10):841-7. PubMed ID: 16957801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The independent reduction in mortality associated with guideline-directed medical therapy in patients with coronary artery disease and heart failure with reduced ejection fraction.
    Wolfe NK; Mitchell JD; Brown DL
    Eur Heart J Qual Care Clin Outcomes; 2021 Jul; 7(4):416-421. PubMed ID: 32324852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating Guideline Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction Post-coronary Artery Bypass Grafting.
    Kabulski GM; Boughner T; Szymanski TW; Sokos GG; Kido K
    J Pharm Pract; 2023 Dec; 36(6):1370-1374. PubMed ID: 35926866
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimal Heart Failure Medical Therapy and Mortality in Survivors of Cardiogenic Shock: Insights From the FRENSHOCK Registry.
    Matsushita K; Delmas C; Marchandot B; Roubille F; Lamblin N; Leurent G; Levy B; Elbaz M; Champion S; Lim P; Schneider F; Khachab H; Carmona A; Trimaille A; Bourenne J; Seronde MF; Schurtz G; Harbaoui B; Vanzetto G; Biendel C; Labbe V; Combaret N; Mansourati J; Filippi E; Maizel J; Merdji H; Lattuca B; Gerbaud E; Bonnefoy E; Puymirat E; Bonello L; Morel O
    J Am Heart Assoc; 2024 Mar; 13(5):e030975. PubMed ID: 38390813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions to improve guideline compliance following coronary artery bypass grafting.
    Yam FK; Akers WS; Ferraris VA; Smith K; Ramaiah C; Camp P; Flynn JD
    Surgery; 2006 Oct; 140(4):541-7; discussion 547-52. PubMed ID: 17011901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.